MENS (JYONG BIOTECH LTD) is held by 13 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($556,334), GEODE CAPITAL MANAGEMENT, LLC ($138,098), UBS Group AG ($80,331). Net institutional sentiment: Mixed.
13
Holders
Avg rating(1 Elite)
$890,953
Total Value
33% (18)
Fund Consensus
6 buying - 12 selling
Smart Money Verdict40Weak MomentumSplit Signals
Get 5 free verdicts/month - sign up in 10 seconds
See how MENS's score breaks down across 4 SEC sources
Held by 13 funds
1 elite
13F: Insider & Congress:
Fund | Action | Shares | Value | Weight | Est. P&L | Conviction |
|---|---|---|---|---|---|---|
Decreased | 258,760(-0.8%) | $556,334 | 0.0% | -52.37% | 0 | |
Decreased | 64,232(-0.2%) | $138,098 | 0.0% | -95.27% | 0 | |
Decreased | 37,363(-74.3%) | $80,331 | 0.0% | -54.20% | 0 | |
Decreased | 14,590(-63.8%) | $31,368 | 0.0% | -89.43% | 0 | |
New | 13,927 | $29,943 | 0.0% | -6.07% | 27 | |
Decreased | 6,301(-77.6%) | $13,547 | 0.0% | -77.40% | 0 | |
Increased | 5,189(+46.6%) | $11,156 | 0.0% | -43.52% | 16 | |
Decreased | 5,679(-6.2%) | $10,790 | 0.0% | -52.37% | 0 | |
Increased | 3,872(+4.8%) | $8,325 | 0.0% | -51.27% | 12 | |
Decreased | 2,787(-74.4%) | $5,992 | 0.0% | -52.37% | 0 | |
Increased | 1,881(+44.7%) | $4,044 | 0.0% | -94.29% | 13 | |
New | 266 | $1,000 | 0.0% | -6.07% | 17 | |
New | 11,767 | $25 | 0.0% | -6.07% | 15 | |
Exited | 0(-100.0%) | $1,659 | 0.0% | -49.29% | 0 | |
Exited | 0(-100.0%) | $806 | 0.0% | -49.29% | 0 | |
Exited | 0(-100.0%) | $274,762 | 0.0% | -49.29% | 0 | |
Exited | 0(-100.0%) | $56,177 | 0.0% | -49.29% | 0 | |
Exited | 0(-100.0%) | $91,569 | 0.0% | -49.29% | 0 |
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
410 holders · $577.8B
UNHUNITEDHEALTH GROUP INC409 holders · $155.8B
JNJJOHNSON & JOHNSON391 holders · $327.3B
DHRDANAHER CORP DEL388 holders · $82.5B
ISRGINTUITIVE SURGICAL INC388 holders · $102.1B
TMOTHERMO FISHER SCIENTIFIC INC387 holders · $127.1B
BSXBOSTON SCIENTIFIC CORP386 holders · $67.5B
MRKMERCK & CO INC381 holders · $175.6B
ABBVABBVIE INC378 holders · $212.3B
ABTABBOTT LABORATORIES376 holders · $108.9B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer